Hong Kong Communications Stock News

Earnings shift draws fresh attention to InnoCare Pharma InnoCare Pharma (SEHK:9969) has drawn fresh attention after reporting full year 2025 sales of CN¥2,374.91 million and net income of CN¥642.47 million, compared with a net loss a year earlier. See our latest analysis for InnoCare Pharma. The earnings swing has coincided with strong price momentum, with a 31.19% 1 month share price return and a 24.16% year to date share price return at HK$15.52. The 1 year total shareholder return of...

Fosun International (SEHK:656) has come under closer focus after reporting a larger net loss for 2025, withholding a dividend for the year, and outlining a higher dividend payout framework starting from the 2026 financial year. See our latest analysis for Fosun International. The recent dividend decision and larger 2025 net loss come after a mixed share price pattern, with a 19.5% 1 month share price return and a 9.91% 1 year total shareholder return contrasting with weaker multi year total...

Recent share performance and business snapshot Ascentage Pharma Group International (SEHK:6855) has drawn investor attention after recent share price moves, with returns of about 13% over the past week and 15% over the past month. The Suzhou based clinical stage biotech focuses on therapies for cancers, chronic hepatitis B and age related diseases in Mainland China. It generated HK$574.12 million in revenue and reported a net loss of HK$1,242.77 million. See our latest analysis for Ascentage...

Why Angelalign Technology’s latest earnings and dividends matter for investors Angelalign Technology (SEHK:6699) has drawn fresh attention after releasing full year 2025 earnings, alongside a proposed special dividend of HK$4.99 per share and affirming its regular annual payout. See our latest analysis for Angelalign Technology. Since these results and dividend announcements, the share price has gained momentum, with a 30 day share price return of 11.71%, a year to date share price return of...

Those following along with Shenzhou International Group Holdings Limited ( HKG:2313 ) will no doubt be intrigued by the...

The market seemed underwhelmed by last week's earnings announcement from Guangdong Kanghua Healthcare Group Co., Ltd...

The recent earnings posted by China Hongguang Holdings Limited ( HKG:8646 ) were solid, but the stock didn't move as...

Xtep International Holdings Limited ( HKG:1368 ) shareholders (or potential shareholders) will be happy to see that the...

Beijing Xunzhong Communication Technology Co., Ltd. ( HKG:2597 ) just released a solid earnings report, and the stock...

We wouldn't blame Great Wall Terroir Holdings Limited ( HKG:524 ) shareholders if they were a little worried about the...

One thing we could say about the analysts on Metallurgical Corporation of China Ltd. ( HKG:1618 ) - they aren't...

As global markets navigate the complexities of Middle East tensions and energy market volatility, Asian small-cap stocks present intriguing opportunities amid a backdrop of mixed economic signals. With key indices showing resilience and geopolitical uncertainties influencing investor sentiment, identifying promising small-cap companies requires a focus on those with robust fundamentals and strategic insider actions that align with current market dynamics.

The analysts covering C&D International Investment Group Limited ( HKG:1908 ) delivered a dose of negativity to...

The market was pleased with the recent earnings report from Chaoju Eye Care Holdings Limited ( HKG:2219 ), despite the...

FWD Group Holdings: recent performance snapshot FWD Group Holdings (SEHK:1828) has drawn investor attention after recent share price moves, with the stock showing mixed short term returns and a last close of HK$31.18 on the Hong Kong market. See our latest analysis for FWD Group Holdings. Recent trading has been choppy, with a 1 day share price return of 1.52% decline and a 7 day share price return of 2.63% gain, set against a 30 day share price return of 10.66% decline and a year to date...

Bank of China Limited reported its full-year 2025 results, with net interest income of CNY 440.71 billion and net income of CNY 243.02 billion, and the board recommended a 2025 final dividend of CNY 1.169 per 10 shares, subject to shareholder approval. The bank also confirmed Ms. Huang Xueling’s appointment as Executive Vice President in late March 2026, highlighting ongoing leadership renewal alongside a higher proposed cash return to shareholders. We’ll now examine how the higher proposed...

Why the latest results matter for dividend focused investors China Merchants Port Holdings (SEHK:144) has reported full year 2025 results with sales of HK$13,354 million and net income of HK$6,504 million, alongside a recommended lower final dividend of HK$0.489 per share. The board’s proposal compares with a final dividend of HK$0.636 per share for 2024. This may prompt investors to reassess how earnings quality, payout levels and long term income expectations line up for the stock after...

What recent performance suggests about China Literature’s current setup China Literature (SEHK:772) has caught attention after a mixed stretch in its share performance, with a roughly 19% decline over the past month and about 25% decline over the past 3 months. See our latest analysis for China Literature. At a latest share price of HK$25.8, China Literature’s short term share price momentum has been weak, with a 30 day share price return of a 15.24% decline and a 90 day share price return of...

Geely Automobile Holdings (SEHK:175) is back in focus after Volvo Cars and Geely Auto signed a memorandum of understanding that would make Volvo the exclusive importer and commercial operator for Lynk & Co vehicles in Europe. See our latest analysis for Geely Automobile Holdings. The memorandum of understanding appears to have arrived at a time when momentum in Geely Automobile Holdings' shares has been strong, with a 1 month share price return of 45.60% and a year to date share price return...

Why AIA Group Is Back on Investors’ Radar AIA Group (SEHK:1299) has attracted fresh attention after a year total return of 66.5%. This has prompted investors to reassess its HK$901.1b valuation, recent share performance and fundamentals. See our latest analysis for AIA Group. While the latest 1 day share price return of 1.54% is negative and short term moves have been mixed, the 1 year total shareholder return of 66.54% points to stronger momentum building over a longer horizon around AIA...

If you are wondering whether BYD’s current share price reflects its true worth, the recent mix of returns gives plenty to think about. The stock is recently trading at HK$103.9, with a 9.7% gain over 30 days, a 5.2% return year to date, but a 4.6% decline over the last year and a 41.1% and 91.3% return over 3 and 5 years respectively. These moves sit against a backdrop of ongoing investor interest in the electric vehicle and battery space. Sentiment can shift quickly as policies,...

As global markets navigate the complexities of Middle East tensions and energy market volatility, major indices like the Nasdaq Composite and S&P 500 have demonstrated resilience with notable gains. In this context, penny stocks—often representing smaller or newer companies—continue to capture investor interest due to their potential for growth at a lower entry cost. While the term "penny stocks" may seem outdated, these investments can still offer valuable opportunities when aligned with...

Key recent share performance Alphamab Oncology (SEHK:9966) has drawn attention after a mixed share performance, with a gain over the past week and month that contrasts with negative moves over the past 3 months and year to date. See our latest analysis for Alphamab Oncology. The recent 7 day share price return of 15.9% and 30 day return of 15.16% off a HK$9.04 share price contrast with a weaker 90 day share price return of 11.37% and a mixed long term picture, with a 1 year total shareholder...

Why China Coal Energy’s latest earnings and dividend proposal matter China Coal Energy (SEHK:1898) has moved back into focus after releasing its full year 2025 results, alongside a proposal for an ordinary final dividend of RMB 0.217 per share and an upcoming earnings call. The new figures, including sales of CNY 147,120.98 million, revenue of CNY 148,056.7 million and net income of CNY 17,883.58 million, provide updated data to assess profitability, income potential and valuation. See our...